CYTH - Cyclo Therapeutics, Inc.
0.7206
0.010 1.374%
Share volume: 188,267
Last Updated: 03-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.01
0.01%
Summary score
29%
Profitability
35%
Dept financing
25%
Liquidity
6%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-96.09%
Return on sales
-2703.02%
Return on invested capital
0%
Total debt ratio
160.67%
Debt ratio change over timeo
0%
Current Ratio
0.86%
Quick Ratio
0.82%
Cash Position Ratio
0.43%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-90.58%
Return on sales
-2711.91%
Return on invested capital
0%
Total debt ratio
180.19%
Debt ratio change over timeo
0%
Current Ratio
0.77%
Quick Ratio
0.75%
Cash Position Ratio
0.43%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-6.79%
Return on sales
-194.14%
Return on invested capital
0%
Total debt ratio
64.09%
Debt ratio change over time
0%
Current Ratio
1.45%
Quick Ratio
1.42%
Cash Position Ratio
1.09%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYTH | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.63% | 6.54% | 16.49% |
| Return on assets | -96.09% | 3.07% | 3.1% | 15.3% |
| Return on sales | -2703.02% | 30.43% | 28.58% | 7.81% |
| Return on invested capital | 0% | 5.33% | 3.53% | -56.8% |
| Profitability | 0% | 80% | 54% | 54% |
| Total debt ratio | 160.67% | 92.23% | 67.28% | 20.78% |
| Debt ratio change over time | 0% | 20.48% | 134.64% | -1.07% |
| Dept financing | 25% | 18% | 35% | 3% |
| Current Ratio | 0.77% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0.75% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 0.43% | 0.47% | 0.47% | 5.59% |
| Liquididy | 9% | 17% | 13% | 75% |
| Short-term ratios | CYTH | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -1.58% |
| Return on assets | -90.58% | 2.13% | 0.76% | -2.3% |
| Return on sales | -2711.91% | 21.39% | 4.39% | -272.71% |
| Return on invested capital | 0% | 0% | 0% | -13.26% |
| Profitability | 50% | 50% | 14% | 0% |
| Total debt ratio | 180.19% | 93.35% | 67.02% | 10.28% |
| Debt ratio change over time | 0% | 0% | 15.75% | -0.69% |
| Dept financing | 25% | 13% | 34% | 1% |
| Current Ratio | 0.77% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0.75% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 0.43% | 0.47% | 0.47% | 5.59% |
| Liquididy | 5% | 7% | 7% | 75% |
